Back to mobile site

Form EFFECT Mersana Therapeutics,

January 9, 2026 6:04 AM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 8, 2026
Accession Number: 0001104659-26-001281
Submission Type: POS AM
CIK: 0001442836
Company Name: Mersana Therapeutics, Inc.
File Number: 333-271766


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings